Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Wheatley

Showing results (81-90 of 145) with videos related to

Pageof 15
Sort By:
Blood|September 22, 2007
Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypesBridget S Wilkins, Wendy N Erber, David Bareford, et al.
Health Technology Assessment (Winchester, England)|September 2, 2016
Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson's disease: a large pragmatic randomised controlled trial (PD REHAB)Carl E Clarke, Smitaa Patel, Natalie Ives, et al.
Health Technology Assessment (Winchester, England)|June 4, 2019
Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCTNicholas Ja Webb, Rebecca L Woolley, Tosin Lambe, et al.
Pediatric Blood & Cancer|November 9, 2018
The utility of routine surveillance screening with magnetic resonance imaging to detect tumor recurrence/progression in children with high-grade central nervous system tumors: a systematic reviewSimon P Stevens, Caroline Main, Simon Bailey, et al.
Blood|July 11, 2013
Clofarabine doubles the response rate in older patients with acute myeloid leukemia but does not improve survivalAlan K Burnett, Nigel H Russell, Ann E Hunter, et al.
Journal of Neuro-Oncology|June 28, 2018
The utility of routine surveillance screening with magnetic resonance imaging (MRI) to detect tumour recurrence in children with low-grade central nervous system (CNS) tumours: a systematic reviewSimon P Stevens, Caroline Main, Simon Bailey, et al.
Neuro-Oncology Advances|May 20, 2022
Phase II study of intravenous etoposide in patients with relapsed ependymoma (CNS 2001 04)John R Apps, Shanna Maycock, David W Ellison, et al.
Lancet (London, England)|February 17, 2009
Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trialAnnie M Young, Lucinda J Billingham, Gulnaz Begum, et al.
BMJ (Clinical Research Ed.)|August 8, 2012
Physiotherapy intervention in Parkinson's disease: systematic review and meta-analysisClaire L Tomlinson, Smitaa Patel, Charmaine Meek, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 18, 2014
Hyperfractionated Accelerated Radiotherapy (HART) with maintenance chemotherapy for metastatic (M1-3) Medulloblastoma--a safety/feasibility studyRoger E Taylor, Andrew J Howman, Keith Wheatley, et al.
Pageof 15

Showing results (81-90 of 145) with videos related to

Sort By:
Pageof 15
Blood|September 22, 2007
Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypesBridget S Wilkins, Wendy N Erber, David Bareford, et al.
Health Technology Assessment (Winchester, England)|September 2, 2016
Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson's disease: a large pragmatic randomised controlled trial (PD REHAB)Carl E Clarke, Smitaa Patel, Natalie Ives, et al.
Health Technology Assessment (Winchester, England)|June 4, 2019
Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCTNicholas Ja Webb, Rebecca L Woolley, Tosin Lambe, et al.
Pediatric Blood & Cancer|November 9, 2018
The utility of routine surveillance screening with magnetic resonance imaging to detect tumor recurrence/progression in children with high-grade central nervous system tumors: a systematic reviewSimon P Stevens, Caroline Main, Simon Bailey, et al.
Blood|July 11, 2013
Clofarabine doubles the response rate in older patients with acute myeloid leukemia but does not improve survivalAlan K Burnett, Nigel H Russell, Ann E Hunter, et al.
Journal of Neuro-Oncology|June 28, 2018
The utility of routine surveillance screening with magnetic resonance imaging (MRI) to detect tumour recurrence in children with low-grade central nervous system (CNS) tumours: a systematic reviewSimon P Stevens, Caroline Main, Simon Bailey, et al.
Neuro-Oncology Advances|May 20, 2022
Phase II study of intravenous etoposide in patients with relapsed ependymoma (CNS 2001 04)John R Apps, Shanna Maycock, David W Ellison, et al.
Lancet (London, England)|February 17, 2009
Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trialAnnie M Young, Lucinda J Billingham, Gulnaz Begum, et al.
BMJ (Clinical Research Ed.)|August 8, 2012
Physiotherapy intervention in Parkinson's disease: systematic review and meta-analysisClaire L Tomlinson, Smitaa Patel, Charmaine Meek, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 18, 2014
Hyperfractionated Accelerated Radiotherapy (HART) with maintenance chemotherapy for metastatic (M1-3) Medulloblastoma--a safety/feasibility studyRoger E Taylor, Andrew J Howman, Keith Wheatley, et al.
Pageof 15